CRDF Cardiff Oncology, Inc.
Healthcare · Market cap: $56.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $365.4K | $0 |
| 2022-Q4 | $14.3K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $63.6K | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $1.0M | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $710.5K | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $66.5K | $0 |
| 2026-Q3 | $1.0M | $0 |
| 2026-Q4 | $0 | $0 |
Bought$3.3M18 buy days
Sold$00 sell days
Net insider flow+$3.3Mnet buying · 5 years
Latest trade2026-07-14PACE GARY W
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | Buy | PACE GARY W | Director | 687,285 | $1.46 | $1,000.0K | 1 |
| 2026-07-14 | Buy | Mohindru Mani | CEO | 34,364 | $1.46 | $50.0K | 1 |
| 2026-06-18 | Buy | PACE GARY W | Director | 30,000 | $1.22 | $36.6K | 1 |
| 2026-06-18 | Buy | Mohindru Mani | CEO | 24,703 | $1.21 | $29.9K | 1 |
| 2025-07-30 | Buy | PACE GARY W | Director | 290,000 | $2.45 | $710.5K | 2 |
| 2024-12-18 | Buy | Levine James E. | CFO | 2,400 | $5.00 | $12.0K | 1 |
| 2024-12-17 | Buy | Levine James E. | CFO | 2,752 | $5.42 | $14.9K | 1 |
| 2024-12-16 | Buy | Levine James E. | CFO | 2,564 | $3.83 | $9.8K | 1 |
| 2024-12-12 | Buy | TANNENBAUM RENEE P | Director | 10,000 | $3.42 | $34.2K | 1 |
| 2024-12-11 | Buy | PACE GARY W | Director | 361,615 | $2.60 | $940.2K | 2 |
| 2023-12-19 | Buy | PACE GARY W | Director | 30,000 | $1.37 | $41.1K | 1 |
| 2023-11-10 | Buy | PACE GARY W | Director | 22,950 | $0.98 | $22.5K | 1 |
| 2022-11-25 | Buy | Erlander Mark | CEO | 10,000 | $1.43 | $14.3K | 1 |
| 2022-09-19 | Buy | White Lale | Director | 15,000 | $1.64 | $24.6K | 1 |
| 2022-09-16 | Buy | Levine James E. | CFO | 30,000 | $1.56 | $46.8K | 1 |
| 2022-09-16 | Buy | Armitage James O | Director | 13,000 | $1.56 | $20.3K | 1 |
| 2022-09-15 | Buy | PACE GARY W | Director | 150,000 | $1.71 | $256.5K | 1 |
| 2022-09-15 | Buy | TANNENBAUM RENEE P | Director | 10,000 | $1.72 | $17.2K | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| PACE GARY W | Director | $3.0M | $0 | 2026-07-14 |
| Levine James E. | CFO | $83.5K | $0 | 2024-12-18 |
| Mohindru Mani | CEO | $79.9K | $0 | 2026-07-14 |
| TANNENBAUM RENEE P | Director | $51.4K | $0 | 2024-12-12 |
| White Lale | Director | $24.6K | $0 | 2022-09-19 |
| Armitage James O | Director | $20.3K | $0 | 2022-09-16 |
| Erlander Mark | CEO | $14.3K | $0 | 2022-11-25 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-12-11 → 2024-12-18 | 3 | $1.0M | 48 | -31.7% (-29.0% raw) | -16.2% (-22.9% raw) | -32.5% (-37.1% raw) | closed |
| 2022-09-15 → 2022-09-19 | 5 | $365.4K | 49 | -2.0% (-3.0% raw) | -19.0% (-19.5% raw) | +2.3% (+3.0% raw) | closed |
| 2021-03-04 → 2021-03-26 | 7 | $298.5K | 61 | -17.9% (-15.1% raw) | -32.3% (-28.0% raw) | -32.9% (-32.1% raw) | closed |
| 2020-05-11 → 2020-05-14 | 8 | $810.0K | 66 | +45.3% (+52.8% raw) | +175.1% (+193.8% raw) | +739.3% (+774.6% raw) | closed |
| 2018-06-08 → 2018-06-20 | 3 | $51.0K | 34 | -12.3% (-19.6% raw) | -27.9% (-27.8% raw) | -34.6% (-33.3% raw) | closed |
| 2016-12-14 → 2016-12-19 | 3 | $71.3K | 28 | – | – | – | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.